These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 31087753)
1. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata. Gautam RK; Singh Y; Gupta A; Arora P; Khurana A; Chitkara A J Cosmet Dermatol; 2020 Jan; 19(1):234-240. PubMed ID: 31087753 [TBL] [Abstract][Full Text] [Related]
2. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. Tembhre MK; Sharma VK Br J Dermatol; 2013 Sep; 169(3):543-8. PubMed ID: 23607748 [TBL] [Abstract][Full Text] [Related]
3. Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata. Yuksek T; Gonul M; Kartal SP; Gungor EB; Hatil SI Arch Dermatol Res; 2024 May; 316(6):205. PubMed ID: 38787409 [TBL] [Abstract][Full Text] [Related]
4. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients. Loh SH; Moon HN; Lew BL; Sim WY J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1028-1033. PubMed ID: 29283462 [TBL] [Abstract][Full Text] [Related]
5. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications. Waśkiel-Burnat A; Osińska M; Salińska A; Blicharz L; Goldust M; Olszewska M; Rudnicka L Cells; 2021 Dec; 10(12):. PubMed ID: 34943905 [TBL] [Abstract][Full Text] [Related]
7. Serum cytokine and chemokine profiles in patients with alopecia areata. Bilgic O; Sivrikaya A; Unlu A; Altinyazar HC J Dermatolog Treat; 2016; 27(3):260-3. PubMed ID: 26367497 [TBL] [Abstract][Full Text] [Related]
8. Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata. Yang X; Zhang W; Zhao X; Hou W; Wu Y; Feng D; Meng Z; Zhou X Exp Cell Res; 2024 Oct; 442(2):114259. PubMed ID: 39293523 [TBL] [Abstract][Full Text] [Related]
9. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy. Morsy H; Maher R; Negm D J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17 and regulatory T cells cytokine levels and their balance: a prospective, randomised, double-blind, dose-response clinical study. Lee JM; Han HJ; Choi WK; Yoo S; Baek S; Lee J BMC Anesthesiol; 2018 Nov; 18(1):164. PubMed ID: 30409131 [TBL] [Abstract][Full Text] [Related]
12. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age. El-Morsy EH; Eid AA; Ghoneim H; Al-Tameemi KA Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394 [TBL] [Abstract][Full Text] [Related]
13. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins. Safar HA; Mustafa AS; Amoudy HA; El-Hashim A PLoS One; 2020; 15(2):e0228381. PubMed ID: 32027660 [TBL] [Abstract][Full Text] [Related]
14. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata. Elela MA; Gawdat HI; Hegazy RA; Fawzy MM; Abdel Hay RM; Saadi D; Shaker O Arch Dermatol Res; 2016 Mar; 308(2):115-21. PubMed ID: 26796544 [TBL] [Abstract][Full Text] [Related]
15. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320 [TBL] [Abstract][Full Text] [Related]
16. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo. Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555 [TBL] [Abstract][Full Text] [Related]
17. Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations. Czarnowicki T; He HY; Wen HC; Hashim PW; Nia JK; Malik K; Estrada Y; Kimmel GW; Taliercio M; Krueger JG; Guttman-Yassky E Allergy; 2018 Mar; 73(3):713-723. PubMed ID: 29083474 [TBL] [Abstract][Full Text] [Related]
18. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis. Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360 [TBL] [Abstract][Full Text] [Related]
19. The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. Zhang C; Xiao C; Wang P; Xu W; Zhang A; Li Q; Xu X Hum Immunol; 2014 Apr; 75(4):289-96. PubMed ID: 24530745 [TBL] [Abstract][Full Text] [Related]
20. Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance. Kim JE; Lee YJ; Lee KJ; Park SH; Kang H Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]